Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 301–400 of 1,000
Age-related macular degeneration: a perspective on genetic studies
Patel, N., Adewoyin, T., & Chong, V. N. (2007) · Eye · doi:10.1038/sj.eye.6702844 · Cited by 71
Silveira, A. C., Morrison, M. A., Ji, F., Xu, H., Reinecke, J. B., Adams, S. M., Arneberg, T. M., Janssian, M., Lee, J.-E., Yuan, Y., et al. (2010) · Vision Research · doi:10.1016/j.visres.2009.09.016 · Cited by 63
Self-citationTuo, J., Ross, R. J., Reed, G. F., Yan, Q., Wang, J. J., Bojanowski, C. M., Chew, E. Y., Feng, X., Olsen, T. W., Ferris, F. L., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.021 · Cited by 63
Maurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“…as complement factor H (CFH) (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005), complement 3 (C3), complement 2/complement factor B (Gold et al., 2006; Francis et al., 2009), and complement factor H-related 1, 3 (Spencer et al., 2008) exhibit significant positive association in AMD…”
A Novel Role of Complement in Retinal Degeneration
Yu, M., Zou, W., Peachey, N. S., McIntyre, T. M., & Liu, J. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10069 · Cited by 61
Role of Complement Cascade in Abdominal Aortic Aneurysms
Hinterseher, I., Erdman, R., Donoso, L. A., Vrabec, T. R., Schworer, C. M., Lillvis, J. H., Boddy, A. M., Derr, K., Golden, A. M., Bowen, W. D., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227652 · Cited by 73
Kanda, A., Stambolian, D. E., Chen, W., Curcio, C. A., Abecasis, G. R., & Swaroop, A. (2010) · PubMed Central · Cited by 75
Thakkinstian, A., McEvoy, M., Chakravarthy, U., Chakrabarti, S., McKay, G. J., Ryu, E., Silvestri, G., Kaur, I., Francis, P. J., Iwata, T., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws031 · Cited by 66
“Gold, 2006 (32) 1 35 861 897 1 40 340 381 0.”
InfluentialRohrer, B., Coughlin, B., Kunchithapautham, K., Long, Q., Tomlinson, S., Takahashi, K., & Holers, V. M. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.016 · Cited by 62
“The strongest argument in support of the involvement of the AP pathway comes from both animal and human data (e.g., (Bora et al., 2006; Rohrer et al., 2009 and Edwards et al., 2005; Gold et al., 2006; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005)).”
BackgroundWhitmore, S. S., Braun, T. A., Skeie, J. M., Haas, C. M., Sohn, E. H., Stone, E. M., Scheetz, T. E., & Mullins, R. F. (2013) · PubMed Central · Cited by 75
Kopplin, L. J., Igo, R. P., Wang, Y., Sivakumaran, T. A., Hagstrom, S. A., Peachey, N. S., Francis, P. J., Klein, M. L., SanGiovanni, J. P., Chew, E. Y., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.39 · Cited by 71
Machalińska, A., Dziedziejko, V., Mozolewska-Piotrowska, K., Karczewicz, D., Wiszniewska, B., & Machaliński, B. (2009) · Ophthalmic Research · doi:10.1159/000219686 · Cited by 60
A search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways
Logue, M. W., Schu, M., Vardarajan, B. N., Farrell, J., Lunetta, K. L., Jun, G., Baldwin, C. T., DeAngelis, M. M., & Farrer, L. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.007 · Cited by 60
Iannaccone, A., Giorgianni, F., New, D. D., Hollingsworth, T., Umfress, A. C., Alhatem, A., Neeli, I., Lenchik, N. I., Jennings, B., Calzada, J. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145323 · Cited by 68
Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits
International AMD Genomics Consortium (IAMDGC), Grassmann, F., Kiel, C., Zimmermann, M. E., Gorski, M., Grassmann, V., Stark, K., Heid, I. M., & Weber, B. H. F. (2017) · Genome Medicine · doi:10.1186/s13073-017-0418-0 · Cited by 62
Jiao, H., Rutar, M., Fernando, N., Yednock, T. A., Sankaranarayanan, S., Aggio‐Bruce, R., Provis, J. M., & Natoli, R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0278-0 · Cited by 67
“way in AMD, including genetic polymorphisms [17] and an abundance of autoantibodies associated with AMD”
BackgroundSparrow, J. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_5 · Cited by 66
Goto, A., Akahori, M., Okamoto, H., MINAMI, M., Terauchi, N., Haruhata, Y., Obazawa, M., Noda, T., Honda, M., Mizota, A., et al. (2009) · Journal of ocular biology, diseases, and informatics · doi:10.1007/s12177-009-9047-1 · Cited by 64
“rs547154 (C2) is one of the protective haplotype-tagging SNPs originally reported by Gold et al. [ 45 ] who discovered a risk haplotype and two protective haplotypes.”
BackgroundFauser, S., Smailhodzic, D., Caramoy, A., van de Ven, J. P. H., Kirchhof, B., Hoyng, C. B., Klevering, B. J., Liakopoulos, S., & den Hollander, A. I. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6827 · Cited by 65
Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.
Chen, H., Liu, K., Chen, L. J., Hou, P., Chen, W., & Pang, C. P. (2012) · PubMed Central · doi:10.1501/0002208 · Cited by 66
Ross, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60
Despriet, D. D. G., Bergen, A. A. B., Merriam, J. E., Zernant, J., Barile, G. R., Smith, R. T., Barbazetto, I. A., van Soest, S., Bakker, A., de Jong, P. T. V. M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0656 · Cited by 60
Self-citationTherapeutic targeting of the complement system in age‐related macular degeneration: a review
Troutbeck, R., Al‐Qureshi, S., & Guymer, R. H. (2012) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02581.x · Cited by 57
“The population-attributable risk for AMD in individuals with the CFH polymorphism is approximately 50%, and combined analysis of the CFH and CFB/C2 haplotypes is predictive of disease in 74% of all AMD cases.(15) In addition to the highrisk CFB/C2 haplotype, Gold et al.”
BackgroundRastogi, N., & Smith, R. T. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.10.003 · Cited by 63
Self-citationRadeke, M. J., Peterson, K. E., Johnson, L. V., & Anderson, D. H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.05.006 · Cited by 64
Klein, R., Myers, C. E., Meuer, S. M., Gangnon, R. E., Sivakumaran, T. A., Iyengar, S. K., Lee, K. E., & Klein, B. E. K. (2012) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.713 · Cited by 64
Complement cascade functions during brain development and neurodegeneration
Fatoba, O., Itokazu, T., & Yamashita, T. (2021) · FEBS Journal · doi:10.1111/febs.15772 · Cited by 60
Kandasamy, M., Ying, P. C., Ho, A. W. S., Sumatoh, H. R., Schlitzer, A., Hughes, T. R., Kemeny, D. M., Morgan, B. P., Ginhoux, F., & Sivasankar, B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003115 · Cited by 56
Complement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.007 · Cited by 57
“A common haplotype containing genes for both C2 and BF of the classical and alternative pathways, respectively, has been reported to have a protective effect (Gold et al., 2006).”
BackgroundBandyopadhyay, M., & Rohrer, B. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8638 · Cited by 53
McKay, G. J., Silvestri, G., Patterson, C. C., Hogg, R. E., Chakravarthy, U., & Hughes, A. E. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2275 · Cited by 59
“associated with AMD, were genotyped to facilitate correlation of findings in this study with those reported previously.(6,7)”
BackgroundMethodResultInfluentialComplement Factor H 402H Variant and Reticular Macular Disease
Smith, R. T., Merriam, J. E., Sohrab, M. A., Pumariega, N. M., Barile, G., Blonska, A. M., Haans, R., Madigan, D., & Allikmets, R. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.212 · Cited by 60
Self-citationEvidence for association between multiple complement pathway genes and AMD
Dinu, V., Miller, P. L., & Zhao, H. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20204 · Cited by 58
“27) against AMD development in 402H homozygotes [Gold et al., 2006].”
BackgroundGenetics of age-related macular degeneration
Ting, A., Lee, T. K. M., & MacDonald, I. M. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32832f8016 · Cited by 65
Genetic Factors for Choroidal Neovascularization Associated with High Myopia
Leveziel, N., Yu, Y., Reynolds, R. C., Tai, A., Meng, W., Caillaux, V., Calvas, P., ROSNER, B. A., Malecaze, F., Souied, E. H., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9538 · Cited by 65
Kondo, N., Bessho, H., Honda, S., & Negi, A. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.06.040 · Cited by 58
Hageman, G. S., Gehrs, K., Lejnine, S., Bansal, A. T., DeAngelis, M. M., Guymer, R. H., Baird, P. N., Allikmets, R., Deciu, C., Oeth, P., et al. (2011) · Human Genomics · doi:10.1186/1479-7364-5-5-420 · Cited by 57
Self-citationLate-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
Borooah, S., Collins, C. E., Wright, A. F., & Dhillon, B. (2008) · Postgraduate Medical Journal · doi:10.1136/bjo.2008.150151 · Cited by 62
Momozawa, Y., Akiyama, M., Kamatani, Y., Arakawa, S., Yasuda, M., Yoshida, S., Oshima, Y., Mori, R., Tanaka, K., Mori, K., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw335 · Cited by 81
Age-Related Macular Degeneration Preferred Practice Pattern®
Vemulakonda, G. A., Bailey, S. T., Kim, S. J., Kovach, J. L., Lim, J. I., Ying, G., & Flaxel, C. J. (2025) · Ophthalmology · doi:10.1016/j.ophtha.2024.12.018 · Cited by 64
Altered Expression of CD46 and CD59 on Leukocytes in Neovascular Age-Related Macular Degeneration
Singh, A., Faber, C., Falk, M. K., Nissen, M. H., Hviid, T. V. F., & Sørensen, T. L. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.01.036 · Cited by 62
Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes
Thompson, C. L., Klein, R., Klein, R., Xu, Z., Capriotti, J., Joshi, T., Leontiev, D. V., Lee, K. E., Elston, R. C., & Iyengar, S. K. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm164 · Cited by 60
Balaratnasingam, C., Hoang, Q. V., Inoue, M., Curcio, C. A., Dolz‐Marco, R., Yannuzzi, N. A., Dhrami‐Gavazi, E., Yannuzzi, L. A., & Freund, K. B. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.09.008 · Cited by 59
Bayesian variable and model selection methods for genetic association studies
Fridley, B. L. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20353 · Cited by 68
“The most significant were two nonsynonymous SNPs (nsSNPs) being related to AMD risk, with posterior probabilities of genotype effects being 0.36 and 0.31, respectively.”
InfluentialSeddon, J. M., Reynolds, R. C., Yu, Y., & ROSNER, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087047 · Cited by 57
Proteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
Skeie, J. M., & Mahajan, V. B. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2065 · Cited by 56
Complement regulation in the eye: implications for age-related macular degeneration
Wilke, G. A., & Apte, R. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178296 · Cited by 55
“One CFB variant is associated with protection from AMD (94, 95); this variant has demonstrated decreased C3 convertase formation in vitro (96).”
Genomic aspects of age-related macular degeneration
Horie‐Inoue, K., & Inoue, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.013 · Cited by 60
Expression of Complement Component 3 (C3) from an Adenovirus Leads to Pathology in the Murine Retina
Cashman, S. M., Desai, A., Ramo, K., & Kumar-Singh, R. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6002 · Cited by 51
(2011) · Europe PMC (PubMed Central) · Cited by 55
Alterations in Circulating Immune Cells in Neovascular Age-Related Macular Degeneration
Lechner, J., Chen, M., Hogg, R. E., Toth, L., Silvestri, G., Chakravarthy, U., & Xu, H. (2015) · Scientific Reports · doi:10.1038/srep16754 · Cited by 56
“Have history of diabetes (number (%)) 15 (12) 2 (8) 13 (13) 0.”
Age-related macular degeneration: genetic and clinical findings
Kokotas, H., Grigoriadou, M., & Petersen, M. B. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.091 · Cited by 62
“Based on these data, it has been postulated that CFB with reduced activity may provide a lower risk of chronic complement response, leading to AMD (117).”
BackgroundGenetic markers and biomarkers for age-related macular degeneration
Ross, R. J., Verma, V., Rosenberg, K. I., Chan, C.-C., & Tuo, J. (2007) · Expert Review of Ophthalmology · doi:10.1586/17469899.2.3.443 · Cited by 54
Inflammation in the pathogenesis of age-related macular degeneration
Kanda, A., Abecasis, G., & Swaroop, A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.131581 · Cited by 55
Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes
Seddon, J. M., Reynolds, R. C., Yu, Y., & ROSNER, B. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2578 · Cited by 58
“001 TT 129 (16) 762 (36) 46 (16) 191 (28) CT 357 (44) 974 (46) 138 (47) 332 (48) CC 323 (40) 369 (18) 110 (37) 162 (24) CFH rs1410996 .”
Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
Smailhodzic, D., van Asten, F., Blom, A. M., Mohlin, F. C., den Hollander, A. I., van de Ven, J. P. H., van Huet, R. A. C., Groenewoud, J. M. M., Tian, Y., Berendschot, T. T. J. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112682 · Cited by 53
Garland, D. L., Fernandez-Godino, R., Kaur, I., Speicher, K. D., Harnly, J. M., Lambris, J. D., Speicher, D. W., & Pierce, E. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt395 · Cited by 53
Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
García‐Onrubia, L., Valentín-Bravo, F. J., Coco, R. M., González‐Sarmiento, R., Jimeno, J. C. P., Usategui‐Martín, R., & Pastor‐Idoate, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165934 · Cited by 61
A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
Sivakumaran, T. A., Igo, R. P., Kidd, J. M., Itsara, A., Kopplin, L. J., Chen, W., Hagstrom, S. A., Peachey, N. S., Francis, P. J., Klein, M. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025598 · Cited by 56
Ardeljan, C., Ardeljan, D., Abu-Asab, M. S., & Chan, C. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041542 · Cited by 56
“These polymorphisms reside within genes including CFH, CFB/C2, C3 and C5, with CFH having shown the strongest association [37–41].”
BackgroundLü, F., Zhao, P., Fan, Y., Tang, S., Hu, J., Liu, X., Yang, X. Q., Chen, Y., Li, T., Lei, C., et al. (2010) · PubMed Central · doi:10.3390/molecules16010001 · Cited by 54
Complement Factor H Is Critical in the Maintenance of Retinal Perfusion
von Leithner, P. L., Kam, J. H., Bainbridge, J. W., Catchpole, I. R., Gough, G., Coffey, P. J., & Jeffery, G. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080927 · Cited by 57
Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
Qin, S., Dong, N., Yang, M., Wang, J., Feng, X., & Wang, Y. (2021) · Journal of Immunology Research · doi:10.1155/2021/9945725 · Cited by 56
“Of note, both L9H and R32Q mutations of factor B are considered to have a high protective effect on the development of AMD, although this protective effect may be mediated by FB mutations [77, 78].”
BackgroundWu, K. H. C., Tan, A. G., Rochtchina, E., Favaloro, E. J., Williams, A., Mitchell, P., & Wang, J. J. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0223 · Cited by 57
Tanimoto, S., Tamura, H., Ue, T., Yamane, K., Maruyama, H., Kawakami, H., & Kiuchi, Y. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.011 · Cited by 55
ROLE OF GENETIC FACTORS AND INFLAMMATION IN AGE-RELATED MACULAR DEGENERATION
MOSHFEGHI, D. M., & BLUMENKRANZ, M. S. (2007) · Retina · doi:10.1097/iae.0b013e31802e3e9b · Cited by 52
New therapeutic targets in atrophic age-related macular degeneration
Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 55
“Recent genetic studies established association between atrophic AMD and single nucleotide polymorphisms in complement factors H [64-67] and B [68], thus linking abnormal complement regulation with pathogenesis of AMD.”
BackgroundSalomon, R. G., Hong, L., & Hollyfield, J. G. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200206v · Cited by 59
Woodell, A., Coughlin, B., Kunchithapautham, K., Casey, S., Williamson, T., Ferrell, W. D., Atkinson, C., Jones, B. W., & Rohrer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067894 · Cited by 52
“Several of the main genetic risk factors are polymorphisms occurring in complement genes, including the alternative pathway (AP) inhibitor, CFH (complement factor H [4–7]), CFB (complement factor B [8]), C2 (complement component 2 [8]), and C3 (complement component 3 [8,9]).”
BackgroundEmerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration
Malek, G., & Lad, E. M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1709-x · Cited by 53
“Other genetic variants include several within the complement cascade such as complement factor B (BF)/complement component 2 (C2) [112, 113], C3 [113, 114], and complement factor I (CFI) [115].”
BackgroundRistau, T., Paun, C., Ersoy, L., Hahn, M., Lechanteur, Y., Hoyng, C., de Jong, E. K., Daha, M. R., Kirchhof, B., den Hollander, A. I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093459 · Cited by 52
Murinello, S., Mullins, R. F., Lotery, A. J., Perry, V. H., & Teeling, J. L. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11821 · Cited by 51
Innate Immune Network in the Retina Activated by Optic Nerve Crush
Templeton, J. P., Freeman-Anderson, N. E., Nickerson, J. M., Jablonski, M. M., Rex, T. S., Williams, R. W., & Geisert, E. E. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11175 · Cited by 53
Richardson, A. J., Islam, A. F. M., Guymer, R. H., & Baird, P. N. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2423 · Cited by 57
Complement System and Potential Therapeutics in Age-Related Macular Degeneration
Park, Y. G., Park, Y. S., & Kim, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136851 · Cited by 53
“The rs9332739 and rs547154 polymorphisms in C2 are noncoding variants, whereas the rs641153 polymorphism in CFB results in reduced alternative pathway amplification and hemolytic activity of the CFB protein [74,75].”
BackgroundHuman retinal cadmium accumulation as a factor in the etiology of age-related macular degeneration
Wills, N. K., Kalariya, N. M., Ramanujam, V. M. S., Lewis, J. R., Abdollahi, S., Husain, A., & van Kuijk, F. J. G. M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.02.014 · Cited by 51
“…et al., 2005; Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Zareparsi et al., 2005), the genes PLEKHA1/LOC387715/HTRA1 (Rivera et al., 2005; Jakobsdottir et al., 2005; Conley et al., 2006; Maller et al., 2006), as well as factor B and complement component 2 (Gold et al., 2006).”
BackgroundRare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS
Valoti, E., Alberti, M., Iatropoulos, P., Piras, R., Mele, C., Breno, M., Cremaschi, A., Bresin, E., Donadelli, R., Alizzi, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00853 · Cited by 51
Li, Y., Song, D., Song, Y., Zhao, L., Wolkow, N., Tobias, J. W., Song, W., & Dunaief, J. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645903 · Cited by 51
Dual role of Nr2e3 in photoreceptor development and maintenance
Webber, A. L., Hodor, P. G., Thut, C. J., Vogt, T., Zhang, T., Holder, D., & Petrukhin, K. E. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.04.006 · Cited by 50
Advances in the genomics of common eye diseases
Bailey, J. N. C., Sobrin, L., Pericak‐Vance, M. A., Haines, J. L., Hammond, C. J., & Wiggs, J. L. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt396 · Cited by 52
de Córdoba, S. R. (2022) · Immunological Reviews · doi:10.1111/imr.13131 · Cited by 56
Bora, N. S., Matta, B., Lyzogubov, V. V., & Bora, P. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.012 · Cited by 51
Kaur, I., Katta, S., Reddy, R. K., Narayanan, R., Mathai, A., Majji, A. B., & Chakrabarti, S. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4135 · Cited by 51
“The single nucleotide polymorphisms (SNPs) in C2 (rs9332739 [E318D] and rs547154 [IVS10]) and CFB (rs4151667 [L9H] and rs641153 [R32Q]) were observed to be strongly associated with reduced risk of AMD.(19) A strong linkage disequilibrium (LD) was observed between the rs547154 and rs641153 SNPs in two studies of Caucas…”
BackgroundResultInfluentialRisk Factors for Age-Related Maculopathy
Connell, P., Keane, P. A., O’Neill, E. C., Al‐Taie, R., Loane, E., Neelam, K., Nolan, J. M., & Beatty, S. (2009) · Journal of Ophthalmology · doi:10.1155/2009/360764 · Cited by 56
“It is also interesting to note that polymorphisms of the CFH gene may be more closely associated with risk for geographic atrophy than for neovascular ARM [68]; however, not all studies have reported this preferential association with the GA form of ARM [69, 70].”
BackgroundHalawa, O. A., Lin, J. B., Miller, J. W., & Vavvas, D. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122580 · Cited by 48
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Tang, S., Yang, J., Xiao, B., Wang, Y., Lei, Y., Lai, D., & Qiu, Q. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.20 · Cited by 49
“75,76 Furthermore, in the largest metabolome association analysis in AMD to date, 60 plasma metabolites were identified to be associated significantly with AMD, including increased levels of large and extra-large HDL subclasses and decreased levels of very low-density lipoprotein, low-density…”
BackgroundSeddon, J. M., & ROSNER, B. A. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.10.022 · Cited by 54
Montes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47
Naj, A. C., Scott, W. K., Courtenay, M. D., Cade, W. H., Schwartz, S. G., Kovach, J. L., Agarwal, A., Wang, G., Haines, J. L., & Pericak‐Vance, M. A. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12011 · Cited by 49
“…Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005), CFB/C2 (encoding complement factor B and complement component 2, respectively) (Gold et al., 2006; Maller et al., 2006), ARMS2 (age-related maculopathy susceptibility 2)/HTRA1 (encoding HtrA serine peptidase 1) (Rivera et al.,…”
BackgroundResultInfluentialSchmid‐Kubista, K. E., Tosakulwong, N., Wu, Y., Ryu, E., Hecker, L. A., Baratz, K. H., Brown, W. L., & Edwards, A. O. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3975 · Cited by 51
A review of human diseases caused or exacerbated by aberrant complement activation
McGeer, P. L., Lee, M., & McGeer, E. G. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.017 · Cited by 49
Gordon, W. C., & Bazan, N. G. (2013) · Current Eye Research · doi:10.3109/02713683.2013.827211 · Cited by 49
C9-R95X Polymorphism in Patients with Neovascular Age-Related Macular Degeneration
Nishiguchi, K. M., Yasuma, T. R., Tomida, D., Nakamura, M., Ishikawa, K., Kikuchi, M., Ohmi, Y., Niwa, T., Hamajima, N., Furukawa, K., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8425 · Cited by 51
Sohn, E. H., Wang, K., Thompson, S., Riker, M. J., Hoffmann, J. M., Stone, E. M., & Mullins, R. F. (2015) · Retina · doi:10.1097/iae.0000000000000263 · Cited by 46
Nadeau, J. H., & Topol, E. J. (2006) · Nature Genetics · doi:10.1038/ng1006-1095 · Cited by 51
Ferrara, D., & Seddon, J. M. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.0814 · Cited by 46
Plasma Biomarkers of Oxidative Stress and Genetic Variants in Age-Related Macular Degeneration
Brantley, M. A., Osborn, M. P., Sanders, B. J., Rezaei, K. A., Lu, P., Li, C., Milne, G. L., Cai, J., & Sternberg, P. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.033 · Cited by 52
Silva, A. S., Teixeira, A., Bavia, L., Lin, F. L. H., Velletri, R., Belfort, R., & Isaac, L. (2012) · PubMed Central · Cited by 56
Pei, X.-T., Li, X.-X., Bao, Y.-Z., Yu, W.-Z., Yan, Z., Qi, H.-J., Qian, T., & Xiao, H.-X. (2009) · Current Eye Research · doi:10.1080/02713680903003484 · Cited by 46
Liu, K., Chen, L. J., Tam, P. O. S., Shi, Y., Lai, T. Y. Y., Liu, D. T. L., Chiang, S. W. Y., Yang, M., Yang, Z., & Pang, C. P. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.003 · Cited by 49
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.